| An oncogenic enhancer encodes selective selenium dependency in AML K Eagle, Y Jiang, X Shi, M Li, ND Obholzer, T Hu, MW Perez, JV Koren, ... Cell Stem Cell 29 (3), 386-399. e7, 2022 | 27 | 2022 |
| A distinct core regulatory module enforces oncogene expression in KMT2A-rearranged leukemia T Harada, Y Heshmati, J Kalfon, MW Perez, JX Ferrucio, J Ewers, ... Genes & development 36 (5-6), 368-389, 2022 | 17 | 2022 |
| Transcriptional plasticity drives leukemia immune escape K Eagle, T Harada, J Kalfon, MW Perez, Y Heshmati, J Ewers, JV Koren, ... Blood Cancer Discovery 3 (5), 394-409, 2022 | 12 | 2022 |
| Addressing 6 challenges in generative AI for digital health: A scoping review T Templin, MW Perez, S Sylvia, J Leek, N Sinnott-Armstrong PLOS Digital Health 3 (5), e0000503, 2024 | 9 | 2024 |
| Defining the transcriptional control of pediatric AML highlights RARA as a superenhancer-regulated druggable dependency MW Perez, O Sias-Garcia, A Daramola, H Wei, M Terrell, R Rashid, ... Blood Advances 5 (23), 4864-4876, 2021 | 7 | 2021 |
| Rapid-kinetics degron benchmarking reveals off-target activities and mixed agonism-antagonism of MYB inhibitors T Harada, MW Perez, J Kalfon, FD Braes, R Batley, K Eagle, B Nabet, ... bioRxiv, 2023 | 4 | 2023 |
| Rara is a druggable super-enhancer regulated dependency in pediatric AML AS Daramola, M Perez, OS Sias-Garcia, MS Terrell, HY Wei, N Cherayil, ... Blood 134, 281, 2019 | 4 | 2019 |
| Leukemia core transcriptional circuitry is a sparsely interconnected hierarchy stabilized by incoherent feed-forward loops T Harada, J Kalfon, MW Perez, K Eagle, FD Braes, R Batley, Y Heshmati, ... bioRxiv, 2023 | 3 | 2023 |
| EZH2-driven immune evasion defines high-risk pediatric AML with t (16; 21) FUS:: ERG gene fusion NJ Buteyn, CG Burke, VJ Sartori, E Deering-Gardner, ZJ DeBruine, ... bioRxiv, 2024 | | 2024 |
| Designing Oligonucleotide-Based FISH Probe Sets with PaintSHOP MW Perez, CK Camplisson, BJ Beliveau Fluorescence In Situ Hybridization (FISH) Methods and Protocols, 177-189, 2024 | | 2024 |
| Core transcriptional regulatory circuitry in AML T Harada, M Perez, J Kalfon, K Eagle, FD Braes, R Batley, K Stegmaier, ... Cancer Research 83 (7_Supplement), 5749-5749, 2023 | | 2023 |
| Transcriptional Immunoediting of AML Cells after Allogeneic Hematopoietic Stem Cell Transplantation K Eagle, T Harada, J Kalfon, M Perez, Y Heshmati, J Ewers, K Stegmaier, ... Blood 138, 647, 2021 | | 2021 |
| Abstract A55: Defining the transcriptional regulation of pediatric AML as a new strategy to find potential druggable vulnerabilities M Perez, A Daramola, O Sias-Garcia, H Wei, N Cherayil, CY Lin, JS Yi Cancer Research 80 (14_Supplement), A55-A55, 2020 | | 2020 |
| Defining the transcriptional regulation of pediatric AML as a new strategy to find potential druggable vulnerabilities M Perez, A Daramola, O Sias-Garcia, H Wei, N Cherayil, CY Lin, JS Yi CANCER RESEARCH 80 (14), 72-73, 2020 | | 2020 |
| An Oncogenic Enhancer Encodes Selective Selenium Dependency in AML CY Lin, SY Joanna, Y Jiang, D Nakada, M Perez, J Koren, K Eagle Blood 134, 638, 2019 | | 2019 |
| Examination of DNA looping near oncogenes reveals variable patterns of epigenetic landscapes in cancer M Perez, T Johannes Cancer Research 77 (13_Supplement), 5370-5370, 2017 | | 2017 |
| Supplementary Note FT Panel, APC PE-Cy | | |
